Prophylaxis against Pneumocystis carinii pneumonia for HIV-exposed infants in Africa

Lancet

Volumn 360, Issue 9349, 2002, Pages 1966-1968

  Graham, Stephen M ^a  

^a UNIVERSITY OF MALAWI   (Malawi)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; COTRIMOXAZOLE; FANSIDAR;

AFRICA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION PREVENTION; PNEUMOCYSTIS CARINII; PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0037079349     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)11921-0     Document Type: Note

References (20)

1. Grimwade K., Gilks C. Cotrimoxazole prophylaxis in adults infected with HIV in low-income countries. Curr Opin Infect Dis. 14:2001;507-512.
2. Graham S.M., Mtitimila E.I., Kamanga H.S., Walsh A.L., Hart C.A., Molyneux M.E. The clinical presentation and outcome of Pneumocystis carinii pneumonia in Malawian children. Lancet. 355:2000;369-373.
3. Lucas S.B., Peacock C.S., Hounnou A., et al. Disease in children infected with HIV in Abidjan, Cote d'Ivoire. BMJ. 312:1996;335-338.
4. Ikeogu M.O., Wolf B., Mathe S. Pulmonary manifestations in HIV seropositivity and malnutrition in Zimbabwe. Arch Dis Child. 76:1997;124-128.
5. Jeena P.M., Coovadia H.M., Chrystal V. Pneumocystis carinii and cytomegalovirus infections in severely ill, HIV-infected African infants. Ann Trop Paediatr. 16:1997;361-368.
6. Zar H.J., Dechaboon A., Hanslo D., Apolles P., Magnus K., Hussey G. Pneumocystis carinii pneumonia in South African children with human immunodeficiency virus. Pediatr Infect Dis J. 19:2000;603-607.
7. Ruffini D.D., Madhi S.A. The high burden of Pneumocystis carinii pneumonia in African HIV-1-infected children hospitalized for severe pneumonia. AIDS. 16:2002;105-112.
8. Chintu C., Mudenda V., Lucas S., et al. Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study. Lancet. 360:2002;985-990.
9. Gibb D.M., Davison C.F., Holland F.J., Walters S., Novelli V., Mok J. Pneumocystis carinii pneumonia in vertically acquired HIV infection in the British Isles. Arch Dis Child. 70:1994;241-244.
10. Simonds R.J., Oxtoby M.J., Caldwell M.B., Gwinn M.L., Rogers M.F. Pneumocystis carinii pneumonia among US children with perinatally acquired HIV infection. JAMA. 270:1993;470-473.
11. Johann-Liang R., Cervia J.S., Noel G.J. Characteristics of human immunodeficiency virus-infected children at the time of death: an experience in the 1990s. Pediatr Infect Dis J. 16:1997;1145-1150.
12. Doung T., Ades A.E., Gibb D.M., et al. Falling HIV vertical transmission and disease progression rates: estimates from surveillance data in the UK and Eire. BMJ. 319:1999;1227-1229.
13. Revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to Human Immunodeficiency Virus. MMWR. 44:1995;1-11.
14. Fisher R.G., Nagaswaran S., Valentine M.E., McKinney R.E. Jr. Successful prophylaxis against Pneumocystis carinii pneumonia in HIV-infected children using smaller than recommended dosages of trimethoprim-sulfamethoxazole. AIDS Patient Care STDS. 15:2001;263-269.
15. Williams A.J., Duong T., McNally L.M., et al. Pneumocystis carinii pneumonia and cytomegalovirus infection in children with vertically acquired HIV infection. AIDS. 15:2001;335-339.
16. Chokephaibulkit K., Wanachiwanawin D., Chearskul S., et al. Pneumocystis carinii severe pneumonia among human immunodeficiency virus-infected children in Thailand: the effect of a primary prophylaxis strategy. Pediatr Infect Dis J. 18:1999;147-152.
17. UNAIDS Provisional WHO/UNAIDS Secretariat Recommendations on the Use of Cotrimoxazole Prophylaxis in Adults and Children Living with HIV/AIDS in Africa. Geneva: UNAIDS, 2000.
18. Iyer J.K., Milhous W.K., Cortese J.F., Kublin J.G., Plowe C.V. Plasmodium falciparum cross-resistance between trimethoprim and pyrimethamine. Lancet. 358:2001;1066-1067.
19. Abdul-Haq N., Abuhammour W., Asmar B., et al. Nasopharyngeal colonization with Streptococcus pneumoniae in children receiving trimethoprim-sulfamefoxazole prophylaxis. Pediatr Infect Dis J. 18:1999;647-649.
20. Zachariah R., Harries A.D., Spielmann M.P., et al. Changes in Escherichia coli resistance to cotrimoxazole in tuberculosis patients and in relation to cotrimoxazole prophylaxis in Thyolo, Malawi. Trans R Soc Trop Med Hyg. 96:2002;202-204.